253 related articles for article (PubMed ID: 36307991)
1. N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis.
Lin Z; Wan AH; Sun L; Liang H; Niu Y; Deng Y; Yan S; Wang QP; Bu X; Zhang X; Hu K; Wan G; He W
Mol Ther; 2023 Feb; 31(2):517-534. PubMed ID: 36307991
[TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
3. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
5. Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis.
Zhang Z; Gao Q; Wang S
J Cell Mol Med; 2021 Mar; 25(5):2655-2665. PubMed ID: 33533172
[TBL] [Abstract][Full Text] [Related]
6. KCTD15 acts as an anti-tumor factor in colorectal cancer cells downstream of the demethylase FTO and the m6A reader YTHDF2.
Zhang FY; Wu L; Zhang TN; Chen HH
Commun Biol; 2024 Mar; 7(1):262. PubMed ID: 38438714
[TBL] [Abstract][Full Text] [Related]
7. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression.
Qiao Y; Su M; Zhao H; Liu H; Wang C; Dai X; Liu L; Liu G; Sun H; Sun M; Wang J; Li Z; Fan J; Zhang Q; Li C; Situ F; Xue J; Jia Z; Zhang C; Zhang S; Shan C
J Exp Clin Cancer Res; 2024 Apr; 43(1):108. PubMed ID: 38600610
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m
Zhou Y; Wang Q; Deng H; Xu B; Zhou Y; Liu J; Liu Y; Shi Y; Zheng X; Jiang J
Cell Death Dis; 2022 Jan; 13(1):72. PubMed ID: 35064107
[TBL] [Abstract][Full Text] [Related]
9. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
10. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
[TBL] [Abstract][Full Text] [Related]
11. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
12. Novel positioning from obesity to cancer: FTO, an m
Chen J; Du B
J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
[TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
14. FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.
Liu N; Liu C; Wang Z; Wang L; Wang J; Kong J
Clin Exp Pharmacol Physiol; 2023 Apr; 50(4):307-315. PubMed ID: 36628934
[TBL] [Abstract][Full Text] [Related]
15. N
Zhang K; Zhang T; Yang Y; Tu W; Huang H; Wang Y; Chen Y; Pan K; Chen Z
Theranostics; 2022; 12(10):4802-4817. PubMed ID: 35832094
[No Abstract] [Full Text] [Related]
16. The m
Chen LS; Zhang M; Chen P; Xiong XF; Liu PQ; Wang HB; Wang JJ; Shen J
Acta Pharmacol Sin; 2022 May; 43(5):1311-1323. PubMed ID: 34462564
[TBL] [Abstract][Full Text] [Related]
17. FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis.
Ruan DY; Li T; Wang YN; Meng Q; Li Y; Yu K; Wang M; Lin JF; Luo LZ; Wang DS; Lin JZ; Bai L; Liu ZX; Zhao Q; Wu XY; Ju HQ; Xu RH
Oncogene; 2021 Aug; 40(33):5168-5181. PubMed ID: 34218271
[TBL] [Abstract][Full Text] [Related]
18. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
19. FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.
Kang H; Zhang Z; Yu L; Li Y; Liang M; Zhou L
J Cell Biochem; 2018 Jul; 119(7):5676-5685. PubMed ID: 29384213
[TBL] [Abstract][Full Text] [Related]
20. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
